Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

4th Annual Cell Engager Therapeutics Summit 2022 | May 24-26 2022 | Boston, MA

Evvnt Promotion / evvnt
-
24.05.2022 - 26.05.2022  Boston Park Plaza, 50 Park Plaza, 02116 Boston, USA
Time: 09:00 - 15:00
 
Temi della conferenza
With TCEs being studied in both hematological and solid tumors (39 and 34 trials respectively), there are now more than one hundred projects in the preclinical stage.
Early clinical outcomes and novel TCE design modifications have fueled the development and clinical advancement of over 65 bispecific T-cell engagers (TCEs), which are presently in Phase I and Phase II investigations since the Cell Engager Series began.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Speakers: Antara Banerjee Associate Director, Immunology Research and Group Leader, Immuno Biologics Takeda Pharmaceutical Co. Ltd., Julie Bailis Director of Research Amgen Inc and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1011482-1?pid=4832
Ms. Rosie Andre
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2599.0 - USD 4648.0
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinHilfswerk AustriaEuropean Public Health Association (EUPHA)Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAMREF - African Medical and Research FoundationnewTreeÖsterreichische Gesellschaft für Public HealthEuropean Health Forum Gastein